Skip to main content
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · IEX Real-Time Price · USD
24.62
+0.83 (3.49%)
At close: May 17, 2024, 4:00 PM
24.75
+0.13 (0.53%)
After-hours: May 17, 2024, 7:58 PM EDT

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $360.91M in the twelve months ending March 31, 2024, with 370.57% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $7.41M, a -69.39% decrease year-over-year. In the year 2023, Beam Therapeutics had annual revenue of $377.71M with 520.01% growth.

Revenue (ttm)
$360.91M
Revenue Growth
+370.57%
P/S Ratio
5.63
Revenue / Employee
$711,856
Employees
507
Market Cap
2.03B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BrightSpring Health Services 9.37B
Astrana Health 1.45B
Novavax 996.61M
Catalyst Pharmaceuticals 411.35M
UFP Technologies 407.33M
Zai Lab 291.07M
Agios Pharmaceuticals 29.40M
Keros Therapeutics 234.00K
Revenue Rankings

BEAM News

More News